Floatz logo

Deferasirox

Beta-thalassemia Major

Pakistan Blood and Marrow Transplant (PBMT) GroupSmall moleculePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
95/ 100

Competitive context

31 Active assets in the Beta-thalassemia Major cohort.

Asset / SponsorPhaseRating
Deferiprone
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Hydroxyurea
Bahria University
Phase 4BBB
TACROLIMUS
M.D. Anderson Cancer Center
Phase 4BBB
DESFERRIOXAMINE B
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Fludarabine
M.D. Anderson Cancer Center
Phase 4BBB

View all 50 →

Same molecule, other indications

Deferasirox is also rated in:

iron poisoningDormant
A
Indicative ·
82 / 100
View asset →
hemosiderosisDormant
A
Indicative ·
81 / 100
View asset →
iron metabolism diseaseDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →